{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:53:41Z","timestamp":1784307221451,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12954-015-0083-9","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T13:36:31Z","timestamp":1445520991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Risk environments facing potential users of a supervised injection site in Ottawa, Canada"],"prefix":"10.1186","volume":"12","author":[{"name":"The PROUD Community Advisory Committee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Pantalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daina","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Chepesiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tyndall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,22]]},"reference":[{"issue":"4","key":"83_CR1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.drugpo.2004.03.003","volume":"15","author":"C Navarro","year":"2004","unstructured":"Navarro C, Leonard L. Prevalence and factors related to public injecting in Ottawa, Canada: implications for the development of a trial safer injecting facility. Int J Drug Policy. 2004;15(4):275\u201384.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"83_CR2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugpo.2011.08.005","volume":"23","author":"MM Islam","year":"2012","unstructured":"Islam MM, Topp L, Day CA, Dawson A, Conigrave KM. The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. Int J Drug Policy. 2012;23(2):94\u2013102.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"83_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1155\/2012\/297530","volume":"23","author":"KB Laupland","year":"2012","unstructured":"Laupland KB, Embil JM. Reducing the adverse impact of injection drug use in Canada. Can J Infect Dis Med Microbiol. 2012;23(3):106\u20137.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"83_CR4","unstructured":"What is harm reduction? A position statement from the International Harm Reduction Association. London, United Kingdom: International Harm Reduction Association; 2009. http:\/\/www.ihra.net\/what-is-harm-reduction . Accessed 7 Apr 2014."},{"key":"83_CR5","volume-title":"The dynamics of needle exchange and other service provision","author":"P Murphy","year":"2000","unstructured":"Murphy P, Sales P, Choe J, McKearin G, Murphy S. The dynamics of needle exchange and other service provision. San Francisco, CA: American Society of Criminology meeting; 2000."},{"issue":"1","key":"83_CR6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.drugalcdep.2008.05.014","volume":"98","author":"W Small","year":"2008","unstructured":"Small W, Wood E, Lloyd-Smith E, Tyndall M, Kerr T. Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. Drug Alcohol Depend. 2008;98(1):159\u201362.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"83_CR7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1360-0443.2007.01818.x","volume":"102","author":"E Wood","year":"2007","unstructured":"Wood E, Tyndall MW, Zhang R, Montaner JSG, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction. 2007;102(6):916\u20139.","journal-title":"Addiction"},{"key":"83_CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"C Potier","year":"2014","unstructured":"Potier C, Lapr\u00e9vote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48\u201368.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"83_CR9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/002204260203200113","volume":"32","author":"RS Broadhead","year":"2002","unstructured":"Broadhead RS, Kerr TH, Grund JPC, Altice FL. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues. 2002;32(1):329\u201355.","journal-title":"J Drug Issues"},{"key":"83_CR10","unstructured":"Hedrich D, Kerr T, Dubois-Arber F. Drug consumption facilities in Europe and beyond. In: Rhodes T, Hedrich D, editors. Harm reduction: evidence, impacts and challenges. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Scientific Monograph Series. 2010;10:p.305. doi: 10.2810\/29497 ."},{"issue":"9775","key":"83_CR11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BDL Marshall","year":"2011","unstructured":"Marshall BDL, Milloy MJ, Wood E, Montaner JSG, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429\u201337.","journal-title":"Lancet"},{"issue":"4","key":"83_CR12","first-page":"676","volume":"105","author":"AM Salmon","year":"2010","unstructured":"Salmon AM, van Beek I, Amin J, Kaldor J, Maher L. The impact of a supervised injecting facility on ambulance call-outs in Sydney. Australia Addict Abingdon Engl. 2010;105(4):676\u201383.","journal-title":"Australia Addict Abingdon Engl"},{"issue":"1","key":"83_CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/09595230500125047","volume":"24","author":"J Kimber","year":"2005","unstructured":"Kimber J, Dolan K, Wodak A. Survey of drug consumption rooms: service delivery and perceived public health and amenity impact. Drug Alcohol Rev. 2005;24(1):21\u20134.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"83_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1747-597X-1-13","volume":"1","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Lai C, Montaner JSG, Kerr T. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treat Prev Policy. 2006;1(1):13.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"83_CR15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/09595230500167460","volume":"24","author":"K Freeman","year":"2005","unstructured":"Freeman K, Jones CGA, Weatherburn DJ, Rutter S, Spooner CJ, Donnelly N. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug Alcohol Rev. 2005;24(2):173\u201384.","journal-title":"Drug Alcohol Rev"},{"key":"83_CR16","unstructured":"Millson P, Leonard L, Remis R, Strike C, Challacombe L. Injection drug use, HIV and HCV infection in Ontario: The evidence 1992\u20132004. HIV Social, Behavioural and Epidemiological Studies Unit, Faculty of Medicine, University of Toronto, Toronto; 2005. http:\/\/www.health.gov.on.ca\/english\/providers\/pub\/aids\/reports\/injection_druguse_hiv_hcv_infection_ontario_evi.pdf . Accessed Jan 23 2013."},{"issue":"7","key":"83_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0022245","volume":"6","author":"R Pilon","year":"2011","unstructured":"Pilon R, Leonard L, Kim J, Vallee D, De Rubeis E, Jolly AM, et al. Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs. PLoS ONE. 2011;6(7):1\u20137.","journal-title":"PLoS ONE"},{"key":"83_CR18","unstructured":"Bayoumi A, Strike C, Brandeau M, Degani N, Fischer B, Glazier R, et al. Report of the Toronto and Ottawa Supervised Consumption Assessment Study, 2012. St. Michael\u2019s: University of Toronto; 2012. http:\/\/www.catie.ca\/en\/resources\/report-toronto-and-ottawa-supervised-consumption-assessment-study-2012 . Accessed 23 Jan 2013."},{"key":"83_CR19","unstructured":"Leonard L, DeRubeis E, Strike C. Needs assessment for a safer injecting facility in Ottawa, Canada. Ottawa, ON: University of Ottawa; 2008. http:\/\/www.researchgate.net\/publication\/255683793_Needs_Assessment_for_a_Safer_Injecting_Facility_in_Ottawa_Canada ."},{"issue":"2","key":"83_CR20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","volume":"13","author":"T Rhodes","year":"2002","unstructured":"Rhodes T. The risk environment: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85\u201394.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"83_CR21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.healthplace.2011.01.012","volume":"17","author":"SM Goldenberg","year":"2011","unstructured":"Goldenberg SM, Strathdee SA, Gallardo M, Nguyen L, Lozada R, Semple SJ, et al. How important are venue-based HIV risks among male clients of female sex workers? A mixed methods analysis of the risk environment in nightlife venues in Tijuana. Mexico Health Place. 2011;17(3):748\u201356.","journal-title":"Mexico Health Place"},{"issue":"1","key":"83_CR22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.socscimed.2012.10.015","volume":"76","author":"L Richardson","year":"2013","unstructured":"Richardson L, Wood E, Kerr T. The impact of social, structural and physical environmental factors on transitions into employment among people who inject drugs. Soc Sci Med. 2013;76(1):126\u201333. doi: 10.1016\/j.socscimed.2012.10.015 .","journal-title":"Soc Sci Med"},{"key":"83_CR23","first-page":"547","volume-title":"Community-based participatory research for health: from process to outcomes","author":"M Minkler","year":"2010","unstructured":"Minkler M, Wallerstein N. Community-based participatory research for health: from process to outcomes. San Francisco, CA: John Wiley & Sons; 2010. p. 547."},{"issue":"3","key":"83_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","volume":"20","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193\u2013201.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"83_CR25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1521\/aeap.2010.22.3.173","volume":"22","author":"SD Rhodes","year":"2010","unstructured":"Rhodes SD, Malow RM, Jolly C. Community-based participatory research (CBPR): a new and not-so-new approach to HIV\/AIDS prevention, care, and treatment. AIDS Educ Prev. 2010;22(3):173.","journal-title":"AIDS Educ Prev"},{"issue":"2","key":"83_CR26","first-page":"ii3","volume":"82","author":"M Minkler","year":"2005","unstructured":"Minkler M. Community-based research partnerships: challenges and opportunities. J Urban Health. 2005;82(2):ii3\u201312.","journal-title":"J Urban Health"},{"issue":"1","key":"83_CR27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7517-11-26","volume":"11","author":"L Lazarus","year":"2014","unstructured":"Lazarus L, Shaw A, LeBlanc S, Martin A, Marshall Z, Weersink K, et al. Establishing a community-based participatory research partnership among people who use drugs in Ottawa: the PROUD cohort study. Harm Reduct J. 2014;11(1):26.","journal-title":"Harm Reduct J"},{"key":"83_CR28","unstructured":"What is being done about discarded needles in our communities? Ottawa Public Health. http:\/\/ottawa.ca\/en\/residents\/public-health\/healthy-living\/what-being-done-about-discarded-needles-our-communities . Accessed 24 Jan 2013."},{"issue":"1","key":"83_CR29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2011.600389","volume":"38","author":"K DeBeck","year":"2012","unstructured":"DeBeck K. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse. 2012;38(1):55\u201362.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"7","key":"83_CR30","first-page":"889","volume":"165","author":"DM Patrick","year":"2001","unstructured":"Patrick DM, Tyndall MW, Cornelisse PGA, Li K, Sherlock CH, Rekart ML, et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Can Med Assoc J. 2001;165(7):889\u201395.","journal-title":"Can Med Assoc J"},{"issue":"9482","key":"83_CR31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(05)66475-6","volume":"366","author":"T Kerr","year":"2005","unstructured":"Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316\u20138.","journal-title":"Lancet"},{"issue":"3\u20134","key":"83_CR32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/10826080701772355","volume":"43","author":"K Shannon","year":"2008","unstructured":"Shannon K, Rusch M, Morgan R, Oleson M, Kerr T, Tyndall MW. HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs. Subst Use Misuse. 2008;43(3\u20134):521\u201334.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"83_CR33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","volume":"87","author":"T Kerr","year":"2007","unstructured":"Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39\u201345.","journal-title":"Drug Alcohol Depend"},{"key":"83_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-7517-6-9","volume":"6","author":"JA Buxton","year":"2009","unstructured":"Buxton JA, Skutezky T, Tu AW, Waheed B, Wallace A, Mak S. The context of illicit drug overdose deaths in British Columbia, 2006. Harm Reduct J. 2009;6:9.","journal-title":"Harm Reduct J"},{"issue":"1","key":"83_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1747-597X-9-31","volume":"9","author":"E Jozaghi","year":"2014","unstructured":"Jozaghi E, Reid AA, Andresen MA, Juneau A. A cost-benefit\/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa. Canada Subst Abuse Treat Prev Policy. 2014;9(1):31.","journal-title":"Canada Subst Abuse Treat Prev Policy"},{"issue":"1","key":"83_CR36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7517-7-20","volume":"7","author":"N Fairbairn","year":"2010","unstructured":"Fairbairn N, Small W, Van Borek N, Wood E, Kerr T. Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study. Harm Reduct J. 2010;7(1):20.","journal-title":"Harm Reduct J"},{"issue":"1","key":"83_CR37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugpo.2006.11.019","volume":"18","author":"W Small","year":"2007","unstructured":"Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Policy. 2007;18(1):27\u201336.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"83_CR38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1360-0443.2006.01556.x","volume":"101","author":"T Rhodes","year":"2006","unstructured":"Rhodes T, Kimber J, Small W, Fitzgerald J, Kerr T, Hickman M, et al. Public injecting and the need for \u201csafer environment interventions\u201d in the reduction of drug-related harm. Addiction. 2006;101(10):1384\u201393.","journal-title":"Addiction"},{"issue":"7","key":"83_CR39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1503\/cmaj.1040774","volume":"171","author":"E Wood","year":"2004","unstructured":"Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JSG, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Can Med Assoc J. 2004;171(7):731\u20134.","journal-title":"Can Med Assoc J"},{"issue":"2","key":"83_CR40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/00952990601175102","volume":"33","author":"I McKnight","year":"2007","unstructured":"McKnight I, Maas B, Wood E, Tyndall MW, Small W, Lai C, et al. Factors associated with public injecting among users of Vancouver\u2019s supervised injection facility. Am J Drug Alcohol Abuse. 2007;33(2):319\u201325.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"83_CR41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugpo.2008.08.002","volume":"20","author":"C Duff","year":"2009","unstructured":"Duff C. The drifting city: the role of affect and repair in the development of \u201cEnabling Environments.\u201d. Int J Drug Policy. 2009;20(3):202\u20138.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"83_CR42","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jemermed.2011.05.020","volume":"43","author":"N Fairbairn","year":"2012","unstructured":"Fairbairn N, Milloy M-J, Zhang R, Lai C, Grafstein E, Kerr T, et al. Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian setting. J Emerg Med. 2012;43(2):236\u201343.","journal-title":"J Emerg Med"},{"issue":"5","key":"83_CR43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1521\/aeap.2011.23.5.412","volume":"23","author":"H Reddon","year":"2011","unstructured":"Reddon H, Wood E, Tyndall M, Lai C, Hogg R, Montaner J, et al. Use of North America\u2019s first medically supervised safer injecting facility among HIV-positive injection drug users. AIDS Educ Prev. 2011;23(5):412\u201322.","journal-title":"AIDS Educ Prev"},{"issue":"6","key":"83_CR44","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1080\/09540120903373557","volume":"22","author":"LG Johnston","year":"2010","unstructured":"Johnston LG, Whitehead S, Simic-Lawson M, Kendall C. Formative research to optimize respondent-driven sampling surveys among hard-to-reach populations in HIV behavioral and biological surveillance: lessons learned from four case studies. AIDS Care. 2010;22(6):784\u201392.","journal-title":"AIDS Care"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-015-0083-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T16:21:25Z","timestamp":1567268485000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.harmreductionjournal.com\/content\/12\/1\/49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,22]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["83"],"URL":"https:\/\/doi.org\/10.1186\/s12954-015-0083-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,22]]},"article-number":"49"}}